|

EFS of the CardioMech MVRS

RECRUITINGN/ASponsored by CardioMech AS
Actively Recruiting
PhaseN/A
SponsorCardioMech AS
Started2021-07-27
Est. completion2026-09
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations12 sites

Summary

Safety and performance evaluation of the CardioMech Mitral Valve Repair System (MVRS) in patients with degenerative mitral valve regurgitation.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Eighteen (18) years of age or greater
* Moderate to severe (≥3+) or severe (≥4+) mitral valve regurgitation (per American Society of Echocardiography (ASE) guidelines) due to mitral valve prolapse or flail
* Intermediate or high surgical risk for mitral valve repair

Exclusion Criteria:

* History of rheumatic heart disease
* History of prior endocarditis
* History of prior repair or replacement of the mitral valve, or annuloplasty
* Severely calcified mitral leaflet or has evidence of calcification in the grasping area of the leaflets that would prevent leaflet anchor positioning and deployment
* Complex mechanism of MR (leaflet perforation, severe leaflet calcifications, commissural extension, commissural prolapse, multiple flail or prolapsing segments, cleft) present on required imaging

Conditions2

Heart DiseaseMitral Regurgitation

Locations12 sites

Cardiovascular Institute of Los Robles Health System
Thousand Oaks, California, 91360
Northwestern University
Evanston, Illinois, 60208
Ascension St. Francis via Christi
Wichita, Kansas, 67226
Meredith Thunberg, RN, BSNMeredith.Thunberg@cckheart.com
Mayo Clinic
Rochester, Minnesota, 55902
CentraCare Heart & Vascular Center
Saint Cloud, Minnesota, 56303
Jennifer HumbertHumbertJ@centracare.com

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.